(Q46946844)

English

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

scientific article published in December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

based on heuristic

inferred from title

invasive aspergillosis

1 reference

based on heuristic

inferred from title

Raoul Herbrecht

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stéphane de Botton

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Serge Alfandari

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Denis Caillot

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Anne Thiébaut

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Arnaud Pigneux

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Frédéric Bernard

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jérôme Larché

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Françoise Monchecourt

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

110

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2740-2746

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17941026%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Combination antifungal therapy for invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

21 January 2018

Therapeutic outcome in invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy for aspergillosis: is it needed, and which combination?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23109

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46946844&oldid=1970193898"